LEP and breast carcinoma: Accordingly, inhibition of the leptin signaling pathway by using a specific peptide significantly reduced the growth and motility of AnaR breast cancer cells, highlighting the existence of an autocrine feedback loop that sustains the more aggressive behavior of AI resistant breast cancer cells.